BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30251905)

  • 1. The potential of PTPN22 as a therapeutic target for rheumatoid arthritis.
    Carmona FD; Martín J
    Expert Opin Ther Targets; 2018 Oct; 22(10):879-891. PubMed ID: 30251905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.
    Rincón JF; Cano DL; Morales SJ; Jiménez ML; Cobos RE; Bello JR
    Clin Rheumatol; 2016 Jun; 35(6):1457-62. PubMed ID: 26951256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico.
    Torres-Carrillo NM; Ruiz-Noa Y; Martínez-Bonilla GE; Leyva-Torres SD; Torres-Carrillo N; Palafox-Sánchez CA; Navarro-Hernández RE; Rangel-Villalobos H; Oregón-Romero E; Muñoz-Valle JF
    Immunol Lett; 2012 Sep; 147(1-2):41-6. PubMed ID: 22743847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
    van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
    Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN22 -1123G>C polymorphism and anti-cyclic citrullinated protein antibodies in rheumatoid arthritis.
    Muñoz-Valle JF; Padilla-Gutiérrez JR; Hernández-Bello J; Ruiz-Noa Y; Valle Y; Palafox-Sánchez CA; Parra-Rojas I; Gutiérrez-Ureña SR; Rangel-Villalobos H
    Med Clin (Barc); 2017 Aug; 149(3):95-100. PubMed ID: 28291534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status.
    Lee AT; Li W; Liew A; Bombardier C; Weisman M; Massarotti EM; Kent J; Wolfe F; Begovich AB; Gregersen PK
    Genes Immun; 2005 Mar; 6(2):129-33. PubMed ID: 15674368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.
    Gianchecchi E; Palombi M; Fierabracci A
    Autoimmun Rev; 2013 May; 12(7):717-25. PubMed ID: 23261816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma.
    Majorczyk E; Jasek M; Płoski R; Wagner M; Kosior A; Pawlik A; Obojski A; Luszczek W; Nowak I; Wiśniewski A; Kuśnierczyk P
    Eur J Hum Genet; 2007 Oct; 15(10):1043-8. PubMed ID: 17579671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
    Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
    Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) +1858 C>T gene polymorphism in Egyptian cases with rheumatoid arthritis.
    Salama A; Elshazli R; Elsaid A; Settin A
    Cell Immunol; 2014 Jul; 290(1):62-5. PubMed ID: 24880676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN22 1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients.
    Ruiz-Noa Y; Hernández-Bello J; Llamas-Covarrubias MA; Palafox-Sánchez CA; Oregon-Romero E; Sánchez-Hernández PE; Ramírez-Dueñas MG; Parra-Rojas I; Muñoz-Valle JF
    J Clin Lab Anal; 2019 Mar; 33(3):e22710. PubMed ID: 30402903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
    López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
    Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
    Du J; Qiao Y; Sun L; Wang X
    Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.
    Raslan HM; Attia HR; Salama I; Ibrahim MH; Hassan EM; El Hussieny MS; El Menyawi MM; Amr KS
    Rheumatol Int; 2016 Aug; 36(8):1167-75. PubMed ID: 27324632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.
    Elshazli R; Settin A
    Immunobiology; 2015 Aug; 220(8):1012-24. PubMed ID: 25963842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients.
    El-Lebedy D; Raslan H; Ibrahim A; Ashmawy I; El-Aziz SA; Mohammed AM
    Clin Rheumatol; 2017 Sep; 36(9):1981-1987. PubMed ID: 28424905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene.
    Michou L; Lasbleiz S; Rat AC; Migliorini P; Balsa A; Westhovens R; Barrera P; Alves H; Pierlot C; Glikmans E; Garnier S; Dausset J; Vaz C; Fernandes M; Petit-Teixeira E; Lemaire I; Pascual-Salcedo D; Bombardieri S; Dequeker J; Radstake TR; Van Riel P; van de Putte L; Lopes-Vaz A; Prum B; Bardin T; Dieudé P; Cornélis F;
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1649-54. PubMed ID: 17237219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population.
    Ramirez M; Quintana G; Diaz-Gallo LM; Caminos J; Garces M; Cepeda L; Rondon F; Restrepo JF; Egea E; Garavito G; Robledo G; Martin J; Iglesias-Gamarra A
    Clin Exp Rheumatol; 2012; 30(4):520-4. PubMed ID: 22704547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population.
    Tang L; Wang Y; Zheng S; Bao M; Zhang Q; Li J
    Hum Immunol; 2016 Aug; 77(8):692-698. PubMed ID: 27166176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis.
    Carlton VE; Hu X; Chokkalingam AP; Schrodi SJ; Brandon R; Alexander HC; Chang M; Catanese JJ; Leong DU; Ardlie KG; Kastner DL; Seldin MF; Criswell LA; Gregersen PK; Beasley E; Thomson G; Amos CI; Begovich AB
    Am J Hum Genet; 2005 Oct; 77(4):567-81. PubMed ID: 16175503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.